Researchers at the Oregon State University and IDEXX Laboratories have developed a new biomarker called SDMA, short for symmetric dimethylarginine, that can provide earlier detection of kidney disease. (consciouscat.net)
The study did not find significant differences in the symmetric and asymmetric dimethylarginine concentrations. (sciencedaily.com)
Symmetric and asymmetric dimethylarginine concentrations were also measured, as they both play a role in the production of nitric oxide. (sciencedaily.com)